Nrf2 Modulation by Natural Compounds in Aging, Neurodegeneration, and Neuropathic Pain
Pharmaceutics · 16.01.2026 · 18 (1) · 118
DOI: 10.3390/pharmaceutics18010118 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 16.01.2026. Verfasst von Jurga Bernatoniene und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Drug Technology and Social Pharmacy, Faculty of Pharmacy, Medical Academy, Lithuanian University of Health Sciences, Sukileliu Pr. 13, …. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 238 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Council of Lithuania (LMTLT).
Abstract (Originalsprache)
This review summarizes the role of nuclear factor erythroid 2–related factor 2 (Nrf2) as a common link between aging, neurodegeneration, and neuropathic pain. Aging is characterized by oxidative stress and constant inflammation, which coincides with reduced Nrf2 activity and weaker antioxidant responses, increasing vulnerability to diseases. In neurodegenerative disorders—including Alzheimer’s, Parkinson’s, Huntington’s disease, and amyotrophic lateral sclerosis—evidence indicates that impaired Nrf2 signaling contributes to oxidative damage, neuroinflammation, and mitochondrial dysfunction. Furthermore, in neuropathic pain, similar mechanisms are involved, and Nrf2 could play a role as a potential analgesic target because of its role in regulating cellular defense pathways. We also review natural Nrf2 modulators (e.g., flavonoids, other polyphenols, terpenoids, alkaloids), discussing their benefits alongside common translational limitations such as poor solubility, low oral bioavailability, rapid metabolism, and potential safety issues, including possible pro-oxidant effects and chemoresistance. We also outline future directions that should prioritize improving delivery systems, addressing NRF2/KEAP1 gene variations, evaluating combinations with standard therapies, exploring preventive applications, and defining dosing, treatment duration, and long-term safety. Overall, current evidence indicates that Nrf2 modulation is a practical, cross-cutting approach relevant to healthy aging and disease management.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Drug Technology and Social Pharmacy, Faculty of Pharmacy, Medical Academy, Lithuanian University of Health Sciences, Sukileliu Pr. 13, LT-50161 Kaunas, Lithuania.
- Institute of Pharmaceutical Technologies, Faculty of Pharmacy, Medical Academy, Lithuanian University of Health Sciences, Sukileliu Pr. 13, LT-50161 Kaunas, Lithuania.
- OPUSMEDICA Persons, Care & Research-NPO, 29121 Piacenza, Italy.
- Department of Medicine and Health Sciences "V. Tiberio", University of Molise, 86100 Campobasso, Italy.
- Department of Physiology and Pharmacology "Vittorio Erspamer", La Sapienza University, 00185 Rome, Italy.
- Department of Neurology, Lithuanian University of Health Sciences, Eivenių Str. 2, LT-50009 Kaunas, Lithuania.
ORCID-Profile: Jurga Bernatoniene, Dalia M Kopustinskiene, Roberto Casale, Alessandro Medoro, Sergio Davinelli, Luciano Saso
Förderung
- Research Council of Lithuania (LMTLT)
Zitieren
APA
Bernatoniene, J., Kopustinskiene, D. M., Casale, R., Medoro, A., Davinelli, S., Saso, L., & Petrikonis, K. (2026). Nrf2 Modulation by Natural Compounds in Aging, Neurodegeneration, and Neuropathic Pain. Pharmaceutics, 18(1), 118. https://doi.org/10.3390/pharmaceutics18010118
Vancouver
Bernatoniene J, Kopustinskiene DM, Casale R, Medoro A, Davinelli S, Saso L, et al. Nrf2 Modulation by Natural Compounds in Aging, Neurodegeneration, and Neuropathic Pain. Pharmaceutics. 2026;18(1):118. doi:10.3390/pharmaceutics18010118
BibTeX
@article{Bernatoniene2026,
author = {Bernatoniene, Jurga and Kopustinskiene, Dalia M and Casale, Roberto and Medoro, Alessandro and Davinelli, Sergio and Saso, Luciano and Petrikonis, Kestutis},
title = {Nrf2 Modulation by Natural Compounds in Aging, Neurodegeneration, and Neuropathic Pain},
journal = {Pharmaceutics},
year = {2026},
volume = {18},
number = {1},
pages = {118},
doi = {10.3390/pharmaceutics18010118}
}
EUVIMED